4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid,
CS-088,
olmesartan,
omesartan,
RNH 6270,
Olmesartan,
144689-24-7,
Olmesartan Acid,
Votum,
Olme sartan,
RNH-6270,
UNII-8W1IQP3U10,
RNH 6270,
CHEMBL1516,
8W1IQP3U10,
CHEBI:48416,
MFCD00914967,
4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylic acid,
1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid,
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-,
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid,
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid,
4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid,
4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid,
SMR000466337,
Olmesartan [USAN],
Olmesartan [USAN:INN:BAN],
HSDB 8214,
5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid,
AC1L4KLS,
Olmesartan (USAN/INN),
EC 646-413-5,
SCHEMBL94037,
MLS000759446,
MLS001424016,
MLS006011945,
DTXSID2040571,
Olmesartan, >=98% (HPLC),
CTK8E7599,
VTRAEEWXHOVJFV-UHFFFAOYSA-N,
HMS2051K12,
HMS2235O24,
HMS3369I09,
HMS3393K12,
HMS3604J06,
Pharmakon1600-01505206,
ZINC538621,
BCP12007,
KS-00000XI9,
3949AH,
BDBM50241364,
CS 088,
NSC759810,
AKOS015900241,
AKOS024458255,
Olmesartan (RNH6270, CS 088),
AC-9385,
CCG-100868,
CS-0576,
DB00275,
MCULE-9101392328,
NC00118,
NSC-759810,
RP17747,
NCGC00246968-01,
NCGC00246968-02,
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,
AK546552,
AN-31304,
AS-10242,
HY-17004,
SC-22976,
SMR004703526,
AB0109206,
LS-181800,
RT-014852,
FT-0631169,
O-125,
O0507,
C21543,
D05246,
W-5216,
54247-EP2295422A2,
54247-EP2308562A2,
689O247,
L001097,
W-201270,
I14-10085,
Z1583819783,
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate,
1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid,
4-(1-hydroxy-1-methylethyl) -2-propyl-1-{4-[2-(tetrazole -5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid,
4-(1-hydroxy-1-methylethyl) -2-propyl-1-{4-[2-(tetrazole-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid,
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2 inverted exclamation mark -(1H-tetazol-5-yl)[1,1 inverted exclamation mark -biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid,
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (Olmesartan),
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2''-(1H-tetrazol-5-yl)[1,1''-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid,
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2''-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid,
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid,
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid,
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazole-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid,
4-(2-Hydroxy-2-propanyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylic acid,
4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid,
4-(hydroxy-1-methylethyl)-2-propyl-1-{[2''-(1H-tetrazol-5-yl)-1,1''-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid,
5-(1-hydroxy-1-methyl-ethyl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid,
5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid,
5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid.,
OLM,
Benicar,
Olmetec,
omesartan,
Olmesartan medoxomil,
Olmesartan D4,
Olmesartan medoximil,
Cs 866,
cc-480,
3-Mercaptopropyltriethoxysilane,
CS-866,
C24H26N6O3,
2-Dimethylamino-6-hydroxypurine,
CS-088,
CID158781,
DE-092,
C24-H26-N6-O3,
ACN-028432,
CS-O-05965,
A10670,
C437965,
4-(Hydroxy-1-methyethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid,
4-(Hydroxy-1-methyethyl)-2-propyl-1-[[2'-[1H-tetrazol-5-yl]-1,1'-biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic acid,
4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid,